News & Events category:
NIHR Manchester Biomedical Research Centre

Women with a higher Body Mass Index in early adulthood may have a lower risk of developing breast cancer after the menopause because of lasting changes in the structure of their breast tissue.

An innovative NHS test developed in Manchester can help detect if patients with chronic health conditions are not taking their prescribed medications, which can often lead to further health problems.

Researchers at MFT continue to revolutionise the diagnosis of Perrault syndrome, with the latest discovery of a new genetic cause for the rare condition linked to hearing loss and infertility.

A project to evaluate a portable, highly sensitive, rapid point-of-care testing device in Greater Manchester ambulances, has been recognised nationally at the 2026 Advancing Healthcare Awards.

A new drug offers hope for people with hypertrophic cardiomyopathy, the world’s most common inherited heart disease. 

The largest ever UK trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment.

Pioneering cancer researcher Professor Gareth Evans has been awarded an MBE in the King’s Birthday Honours 2026, in recognition of more than 35 years of outstanding contributions to cancer genetics.

A 6-year-old girl is one of more than 80 people worldwide who has finally received a diagnosis of a new condition following a landmark breakthrough by scientists and doctors in Manchester.